Ralph Schiess
Algemeen Directeur bij ONCONETIX, INC.
Vermogen: 32 370 $ op 30-04-2024
Actieve functies van Ralph Schiess
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ONCONETIX, INC. | Algemeen Directeur | 12-01-2024 | - |
| Hoofd Techniek/Wetenschap/O&O | 15-12-2023 | - | |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Algemeen Directeur | 01-01-2010 | - |
| Oprichter | 01-01-2010 | - | |
| Directeur/Bestuurslid | 01-01-2010 | 01-01-2020 | |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2020 | 01-05-2023 |
Loopbaan van Ralph Schiess
Opleiding van Ralph Schiess
| University of Zurich | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
| Zwitserland | 4 |
| Verenigde Staten | 2 |
Operationeel
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Beurs
- Insiders
- Ralph Schiess
- Ervaring